|
Jan 14 |
PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of...
Promotes in-vivo tumor-attacking killer T-cells to... |
|
Jan 06 |
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...
FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE... |
|
Jan 05 |
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference...
FLORHAM PARK, N.J., Jan. 05, 2021 (GLOBE... |
